Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly

This page shows the latest Eli Lilly news and features for those working in and with pharma, biotech and healthcare.

Lilly partners with Merus on development of bispecific antibodies for cancer

Lilly partners with Merus on development of bispecific antibodies for cancer

Eli Lilly has entered a research collaboration agreement with Dutch biotech Merus to develop CD3-engaging bispecific antibodies for the treatment of cancer. ... Merus is set to receive an upfront cash payment of $40m plus an equity investment by Lilly of

Latest news

More from news
Approximately 124 fully matching, plus 626 partially matching documents found.

Latest Intelligence

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    The country is thus home to AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Lundbeck, MSD (Merck Sharp &Dohme), Pfizer, Sanofi and Takeda among others.

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.

  • The impact of COVID-19 on clinical trials The impact of COVID-19 on clinical trials

    Eli Lilly, Bristol-Myers Squibb and Pfizer also have multiple development programmes that are paused or delayed.

  • Working together against COVID-19 Working together against COVID-19

    A number of top pharma companies are included in the newly formed partnership, the COVID-19 Therapeutics Accelerator, including Eli Lilly, J&J, Merck, Novartis, Pfizer and Sanofi.

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    A pack of other antibody programmes involving companies including Amgen, AstraZeneca, Eli Lilly and GlaxoSmithKline is following closely behind, with multiple clinical trials scheduled to start over the summer.

More from intelligence
Approximately 4 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 33 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 17 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

We love what we do and we think it shows.It shows in the work we do, the space we work...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics